JohnM.SlopisMD

Child Neurology

Associate Professor Neuro Oncology

Dr. Slopis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Texas Health Science Center at HoustonResidency, Neurology, 1983 - 1989
McGovern Medical School at UTHealthClass of 1983

PubMed

89 citations
Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety ...
Mary Kay Koenig, Adelaide A. Hebert, Joan Roberson, Joshua Samuels, John M. Slopis
Drugs in R&D. 2012-09-01
182 citations
Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas
Arkadiusz Piotrowski, Jing Xie, Ying F Liu, Andrzej Poplawski, Alicia Gomes
Nature Genetics. 2014-02-01
138 citations
Brain and Ocular Abnormalities in Infants With In Utero Exposure to Cocaine and Other Street Drugs
Rodrigo Dominguez, Antonio Aguirre Vila-Coro, John M. Slopis, Timothy P. Bohan
American Journal of Diseases of Children. 1991-06-01

Journal Articles

Management Guidelines for Paediatric Patients Receiving Chimeric Antigen Receptor T Cell Therapy
Kris M Mahadeo, Julie C Fitzgerald, Marie E Steiner, Partow Kebriaei, Katayoun Rezvani, Ira M Cheifetz, John M Slopis, Paul L Martin, Sattva S Neelapu, Agne Tarasevici..., Nature
Efficacy and Safety of Topical Rapamycin in Patients with Facial Angiofibromas Secondary to Tuberous Sclerosis Complex
Adelaide A Hebert, Joshua A Samuels, John M Slopis, JAMA